- Home
- AMZE vs CRIS Comparison
AMZE vs CRIS Comparison
Compare AMZE & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMZE | CRIS |
|---|---|---|
| Founded | 2019 | 2000 |
| Country | United States | United States |
| Employees | 4 | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3M | 12.9M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | AMZE | CRIS |
|---|---|---|
| Price | $0.38 | $1.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.00 | ★ $16.50 |
| AVG Volume (30 Days) | ★ 1.4M | 209.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | $6,741.66 | $6.13 |
| Revenue Next Year | $100.61 | $7.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.24 | $0.77 |
| 52 Week High | $11.76 | $3.18 |
Technical Indicators
Market Signals| Indicator | AMZE | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 56.15 |
| Support Level | $0.34 | $1.06 |
| Resistance Level | $0.42 | $1.21 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 61.93 | 62.88 |
Price Performance
Historical ComparisonAbout AMZE Amaze Holdings Inc.
Amaze Holdings Inc is a software company dedicated to empowering creators by providing comprehensive software solutions and services that facilitate e-commerce, social commerce, integrated commerce selling experiences, and the distribution of a premium wine brand. The group offers an end-to-end, creator-powered commerce platform offering tools for seamless product creation, modern e-commerce solutions, and scalable managed services.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.